Ardito S, Leonardi W, Longo G
Minerva Med. 1983 Jun 23;74(26):1553-7.
Forty-six in-patients with osteoarticular and tendon inflammatory, traumatic, degenerative and neoplastic diseases were treated with 600 mg/day of proglumetacin for variable periods ranging between 16 and 60 days. Therapeutic efficacy was considerable, with a significant improvement of all symptoms, regardless of the disease condition the patients were suffering from. Tolerance resulted more than satisfactory, as in no case it was rated less than "good".
46例患有骨关节炎、肌腱炎性、创伤性、退行性和肿瘤性疾病的住院患者接受了每日600毫克丙谷美辛治疗，治疗期长短不一，介于16至60天之间。治疗效果显著，所有症状均有明显改善，无论患者所患疾病状况如何。耐受性结果令人十分满意，在所有病例中耐受性评级均不低于“良好”。
